Advanced Therapy of Prostate Disease, Volume 1

Front Cover
PMPH-USA, 2000 - Medical - 670 pages
0 Reviews
From the inital to post-surgical psychological concerns, this book is a complete guide to every step of prostate disease treatment. First, i t describes the physical exam in detail, as well as laboratory and ima ging techniques that can confirm a diagnosis. Then, the pros and cons of treatment methods for every type and variation of prostate cancer a nd benign conditions are discussed. Post-surgical treatment (including behavioral issues) is also outlines.
 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

EPIDEMIOLOGY OF PROSTATE CANCER AN OVERVIEW
1
EPIDEMIOLOGY OF PROSTATE CANCER IN AFRICAN AMERICANS
6
EPIDEMIOLOGY OF PROSTATE CANCER IN AFRICA
14
PROSTATE CANCER AMONG THE CHINESE PATHOLOGIC EPIDEMIOLOGIC AND NUTRITIONAL CONSIDERATIONS
18
EPIDEMIOLOGY OF PROSTATE CANCER IN JAMAICANS
28
EPIDEMIOLOGY OF PROSTATE CANCER IN HISPANIC AMERICANS
31
ASSESSMENT OF RISK OF PROSTATE CANCER ALGORITHMS FOR DIAGNOSIS STAGING AND PROGNOSIS
34
MOLECULAR FACTORS IN THE ASSESSMENT OF PROSTATE CANCER RISK
44
Is EARLY HORMONAL THERAPY PREFERABLE?
332
STAGING FAILURES OF INITIAL THERAPY
340
MANAGEMENT OF PROSTATESPECIFIC ANTIGEN FAILURE AFTER DEFINITIVE THERAPY FOR CLINICALLY LOCALIZED PROSTATE ...
353
MANAGEMENT OF LOCAL FAILURE FOLLOWING TREATMENT OF LOCALIZED PROSTATE CANCER
365
SECONDARY HORMONAL THERAPY
378
MANAGEMENT OF HORMONEREFRACTORY PROSTATE CANCER CHEMOTHERAPY AND IMMUNOTHERAPY
385
THE ARTIFICIAL GENITOURINARY SPHINCTER
405
COLLAGEN THERAPY FOR POSTPROSTATECTOMY INCONTINENCE
410

SCREENING FOR PROSTATE CANCER AN OVERVIEW
50
THE OPTIMAL DIAGNOSTIC TOOL ASSESSMENT OF DIAGNOSTIC MODALITIES TO DETECT EARLY PROSTATE CANCER
60
SCREENING FOR PROSTATE CANCER THE CASE FOR SCREENING
73
SCREENING FOR PROSTATE CANCER THE ARGUMENT FOR CAUTION
80
NATURAL HISTORY OF LOCALIZED ADENOCARCINOMA OF THE PROSTATE
86
PROSTATE PHYSIOLOGY AND REGULATION
92
PATHOBIOLOGY OF PROSTATE DISEASES AN UPDATE
118
MODELS OF PROSTATE CANCER
138
DIAGNOSIS OF PROSTATE CANCER
154
STAGING OF PROSTATE CANCER
159
RADICAL PROSTATECTOMY PATIENT PREPARATION
177
STAGE TA PROSTATE CANCER THE CASE FOR TREATMENT
184
T1BT2NxMO THE CASE FOR OBSERVATION
195
RADICAL RETROPUBIC PROSTATECTOMY FOR CLINICAL STAGE T1BT2 PROSTATE CANCER
202
RADICAL PERINEAL PROSTATECTOMY
210
CONTINENCEENHANCING MODIFICATIONS FOR RADICAL PROSTATECTOMY
219
T1T2NxMO THE CASE FOR EXTERNAL RADIOTHERAPY
229
PERMANENT LOWDOSERATE INTERSTITIAL BRACHYTHERAPY
241
TlBT2NxMO A CASE FOR HORMONAL THERAPY?
253
ROLE OF CRYOSURGERY IN THE TREATMENT OF PROSTATE CANCER
258
SHOULD Tic DISEASE BE TREATED DIFFERENTLY FROM T2 DISEASE?
267
T3T4NxMO THE CASE FOR OBSERVATION
275
T3T4NxMO THE CASE FOR RADIOTHERAPY
284
CLINICALPATHOLOGIC T3NxMO PROSTATE CANCER THE CASE FOR SURGERY
291
NODEPOSITIVE PROSTATE CANCER THE CASE FOR OBSERVATION
300
TxN+MO THE CASE FOR RADIOTHERAPY
304
TxN+MO DISEASE THE CASE FOR EARLY HORMONAL THERAPY AND SURGERY
311
TxNxM 1 THE CASE FOR MONOTHERAPY
317
TxNxM1 THE CASE FOR TOTAL ANDROGEN DEPRIVATION
324
MANAGEMENT OF COMPLICATIONS OF THERAPY ERECTILE DYSFUNCTION
416
ANORECTAL COMPLICATIONS OF PROSTATE SURGERY
423
CHEMOPREVENTION OF CANCER OF THE PROSTATE
428
PROSTATE CANCER MANAGEMENT OF COMPLICATIONS OF THE DISEASE AND ITS THERAPY
446
RANDOMIZED CLINICAL TRIALS IN PROSTATE CANCER
452
HORMONAL AND CELLULAR ASPECTS OF BENIGN PROSTATIC HYPERPLASIA
463
NEED FOR URODYNAMICS AND OTHER TESTING
471
MINIMAL ESSENTIAL DIAGNOSTIC TESTING
481
PATHOPHYSIOLOGY OF BLADDER OUTLET OBSTRUCTION AND VOIDING DYSFUNCTION
491
PREVENTION OF THE PROGRESSION AND LONGTERM COMPLICATIONS OF BENIGN PROSTATIC HYPERPLASIA
498
BENIGN PROSTATIC HYPERPLASIA WHEN TO INTERVENE
508
PREPROCEDURAL EVALUATIONPREPARATION
515
OPTIONS FOR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA ALPHABLOCKERS
531
5 ALPHAREDUCTASE INHIBITORS
543
TRANSURETHRAL NEEDLE ABLATION OF THE PROSTATE FOR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
552
OPTIONS FOR TREATMENT CONTACT
562
FREE BEAM LASER PROSTATECTOMY
568
TRANSURETHRAL RESECTION OF THE PROSTATE
584
TRANSURETHRAL INCISION OF THE PROSTATE
593
OPEN PROSTATECTOMY IN THE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA
600
PHYTOTHERAPY IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
607
PROSTATITIS PATHOPHYSIOLOGY
615
PROSTATITIS DIAGNOSIS
621
PROSTATITIS DIFFERENTIAL DIAGNOSIS CLASSIFICATION AND CONVENTIONAL TREATMENT STRATEGIES
627
PROSTATITIS FACTORS INFLUENCING PROGNOSIS
643
PROSTATITIS ADVANCED THERAPY
650
INDEX
659
Copyright

Other editions - View all

Common terms and phrases

About the author (2000)

Thompson is a Professor and Chairman of the Division of Urology at the University of Texas Health Sciences Center at San Antonio, San Antonio, Texas. He received his undergraduate training at the United States Military Academy, West Point, NY, and his medical training at Tulane University. He completed his residency in urology at Brooke Army Medical Center, followed by a fellowship in urologic oncology at Memorial Sloan-Kettering Cancer Center in New York. Prior to joining the faculty at the University of Texas Health Sciences Center at San Antonio, he served as Chairman of Urology and then Surgery at Brooke Army Medical Center.

Bibliographic information